Table 1.
Baseline data.
| Treatment (n=18) | Control (n=19) | P value | |
|---|---|---|---|
| Sex (F/M) | 6/12 | 7/12 | 0.93 |
| Age (y) | 39 ± 6.4 | 39 ± 4.6 | 0.92 |
| Body Weight (kg) | 96 ± 7.5 | 95 ± 8.7 | 0.92 |
| BMI | 32.25 ± 1.4 | 34.04 ± 2.5 | 0.21 |
| Hip Circumference (cm) | 115 ± 2.5 | 116 ± 4.8 | 0.51 |
| Waist Circumference (cm) | 107 ± 4.8 | 108 ± 6.0 | 0.78 |
| SDBP (mmHg) | 91 ± 5.9 | 90 ± 5.2 | 0.98 |
| SSBP (mmHg) | 135 ± 9.5 | 133 ± 8.7 | 0.76 |
| HR | 77 ± 4.6 | 78 ± 4.0 | 0.68 |
| HS-CRP (mg/L) | 4.5 ± 1.4 | 4.9 ± 1.5 | 0.87 |
| Total cholesterol (mmol/l) | 5.4 ± 0.5 | 5.2 ± 0.9 | 0.80 |
| Triglycerides (mmol/l) | 2.0 ± 0.6 | 3.0 ± 1.1 | 0.16 |
| HDL cholesterol (mmol/l) | 1.1 ± 0.08 | 1.2 ± 0.15 | 0.24 |
| LDL cholesterol (mmol/l) | 3.3 ± 0.3 | 3.1 ± 0.4 | 0.68 |
F, female; M, male; y, year; BMI, body mass index; SDBP, sitting diastolic blood pressure; SSBP, sitting systolic blood pressure; HR, heart rate, beats per minute; HDL, high-density lipoprotein; LDL, low-density lipoprotein. Data shown as mean with (±) 95% CI.